Skip to main content
Neuronetics, Inc. logo

Neuronetics, Inc. — Investor Relations & Filings

Ticker · STIM ISIN · US64131A1051 LEI · 549300T0911ILTTG7P06 US Manufacturing
Filings indexed 659 across all filing types
Latest filing 2026-04-09 Proxy Solicitation & In…
Country US United States of America
Listing US STIM

About Neuronetics, Inc.

https://neurostar.com/neuronetics/

Neuronetics, Inc. is a medical technology company that designs, develops, and markets non-invasive therapies for neurohealth disorders. The company's flagship product is the NeuroStar® Advanced Therapy system, a leading transcranial magnetic stimulation (TMS) treatment. This FDA-cleared, non-drug therapy is primarily indicated for adults with Major Depressive Disorder (MDD) and is also used for decreasing anxiety symptoms. Neuronetics positions itself as a market leader, supported by the largest clinical data set for a TMS therapy for depression and a comprehensive outcomes registry. The company provides extensive sales and customer support to healthcare practices that utilize its systems and is working to expand its technology to cover additional indications.

Recent filings

Filing Released Lang Actions
DEF 14A - Neuronetics, Inc. (0001227636) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
4 - Neuronetics, Inc. (0001227636) (Issuer)
Director's Dealing
2026-03-31 English
4 - Neuronetics, Inc. (0001227636) (Issuer)
Director's Dealing
2026-03-27 English
4 - Neuronetics, Inc. (0001227636) (Issuer)
Director's Dealing
2026-03-24 English
4 - Neuronetics, Inc. (0001227636) (Issuer)
Director's Dealing
2026-03-24 English
4 - Neuronetics, Inc. (0001227636) (Issuer)
Director's Dealing
2026-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.